Zeta Potential Measurement: Assessing Colloidal Stability of Vaccines

At the heart of every liquid vaccine is a delicate balance of forces. Particles in a suspension are naturally drawn together by van der Waals forces. To prevent them from colliding and sticking together, they must possess a repulsive force—typically an electrostatic charge.

When a charged nanoparticle is placed in a liquid, it attracts a thin layer of ions with an opposite charge, known as the Stern layer. Surrounding this is a broader “diffuse layer” where ions are less tightly bound. The boundary where these ions begin to move independently of the particle is called the slipping plane. The electrical potential at this specific boundary is the Zeta Potential (ZP) [2].

Why the ±30 mV Threshold Matters

In the pharmaceutical industry, a zeta potential magnitude of absolute 30 mV (either +30 mV or -30 mV) is generally considered the threshold for “high stability” [3].

• High Zeta Potential (> ±30 mV): Particles strongly repel each other, ensuring the suspension remains stable during shipping and storage.

• Low Zeta Potential (< ±20 mV): Repulsive forces are too weak to overcome van der Waals attraction. This leads to flocculation or aggregation, which can block needles during administration or alter the biological distribution of the vaccine in the body.

The importance of zeta potential has reached new heights with the rise of mRNA vaccines. These vaccines utilize Lipid Nanoparticles (LNPs) to protect fragile mRNA and deliver it into human cells.

1. Ensuring Cellular Uptake: The surface charge of an LNP determines how it interacts with cell membranes. A controlled zeta potential ensures the nanoparticle binds to the target cell without causing toxicity.
2. Adjuvant Consistency: Many traditional vaccines use aluminum-based salts (alums) as adjuvants. The zeta potential of these salts must be carefully monitored to ensure they properly “adsorb” the vaccine antigens.
3. Shelf-Life Prediction: By measuring ZP early in the formulation phase, researchers can forecast long-term stability without waiting months for traditional real-time stability studies [1].

Just as analytical methods for detecting water pollutants are vital for public health safety, zeta potential is a non-negotiable metric for pharmaceutical quality control.

Zeta potential is not a fixed value; it is highly dependent on the environment of the vaccine. A formulation that is stable in a lab vial might become unstable if the following factors are not controlled:

• pH Levels: This is the most critical variable. Changing the pH can flip a particle’s charge from positive to negative. The point where the zeta potential reaches zero is the isoelectric point, where the vaccine is most likely to aggregate [1].

• Ionic Strength: The concentration of salts in the vaccine buffer can “shield” the particle’s charge. According to research from Wyatt Technology, high salt concentrations can compress the electrical double layer, reducing the zeta potential and leading to instability [4].

• Concentration of Additives: Surfactants and stabilizers (like Polysorbate 80) are often added to vaccines to coat particles and provide “steric stabilization,” which works alongside electrostatic repulsion.

Technological advancements have made ZP measurement faster and more accurate. The industry standard is Electrophoretic Light Scattering (ELS).

In this process, a sample of the vaccine is placed in a cell with two electrodes. An electric field is applied, causing the charged particles to move toward the oppositely charged electrode. By using a laser to measure the speed of these particles—a value known as electrophoretic mobility—specialized software calculates the zeta potential using the Henry Equation [5].

Instruments like the Malvern Zetasizer or the Wyatt Mobius allow researchers to perform these measurements in minutes, providing real-time feedback during the manufacturing process [3]. This level of precision is similar to how NMR is transforming food quality control by providing deep molecular insights into complex mixtures.

• Definition: Zeta potential is the measure of the electrokinetic potential at the slipping plane of a particle in suspension.

• Stability Benchmark: A value of ±30 mV is typically required to prevent vaccine particles from clumping together.

• mRNA Significance: It is essential for the stability and delivery of lipid nanoparticles (LNPs) used in modern mRNA technology.

• Environmental Sensitivity: pH and salt concentration (ionic strength) are the primary factors that alter zeta potential results.

• Measurement: Electrophoretic Light Scattering (ELS) is the primary method used to determine particle mobility and charge.

Action Plan for Formulation Scientists

1. Identify the Isoelectric Point: Map the zeta potential across a range of pH levels to find the “danger zone” where the formulation is least stable.
2. Optimize Buffer Selection: Choose a buffer that maintains the desired pH and has an ionic strength low enough to prevent charge shielding.
3. Monitor Post-Production: Use ELS to test vaccine batches after simulated transport (vibration and temperature changes) to ensure the zeta potential remains within the stability threshold.

Zeta potential measurement is more than just a laboratory metric; it is a vital safeguard in the global vaccine supply chain. By maintaining high electrostatic repulsion, manufacturers ensure that vaccines remain safe, effective, and ready for administration from the factory to the pharmacy.